Dr. Gross on Neoadjuvant Cemiplimab in Head and Neck Cutaneous Squamous Cell Carcinoma

Dr Gross on the Neoadjuvant Utility of Cemiplimab in CSCCПодробнее

Dr. Rischin Discusses Cemiplimab in Cutaneous Squamous Cell CarcinomaПодробнее

Neoadjuvant cemiplimab in patients with stage II-IV cutaneous squamous cell carcinomaПодробнее

Experience With Immunotherapy in cSCCПодробнее

Update on Cutaneous Cancers of the Head and Neck - Timothy A. Kelsch, MDПодробнее

Neoadjuvant atezolizumab for advanced cutaneous squamous cell carcinomaПодробнее

Dr. Atlas on the Promise of Up-Front Cemiplimab in Locally Advanced CSCCПодробнее

Dr. Gross on the Prognosis of Cutaneous Squamous Cell Carcinoma of the Head and NeckПодробнее

MATISSE: nivolumab in cutaneous squamous cell carcinomaПодробнее

Dr. Rischin on KEYNOTE-048 Results in Head and Neck Squamous Cell CarcinomaПодробнее

Advanced/Metastatic cSCC Treatment OptionsПодробнее

[skin] Effects of cemiplimab used before skin cancer surgeryПодробнее

Cemiplimab prospects: CRC, CSCC & HNSCCПодробнее

Meet surgical oncologist Neil Gross, M.D.Подробнее

Dr. Postow on FDA Approval of Cemiplimab in Metastatic Cutaneous Squamous Cell CarcinomaПодробнее

Dr. Gold on Defining Head and Neck Squamous Cell CarcinomaПодробнее

Biology of Head and Neck Squamous Cell CarcinomaПодробнее

Cutaneous Squamous Cell Carcinoma: What Is Immunotherapy?Подробнее

Surgery Versus Immunotherapy in CSCCПодробнее